Biocon Biologics Inpremzia gets backing from EMA expert panel Ruchika Sharma2 April 2022 12:43 PM ISTInpremzia is a pre-mixed ready-to-use insulin for IV infusion for patients in hospital and other acute care settings.
Biocon, Viatris application for Insulin Aspart rejected by USFDA Ruchika Sharma11 Jan 2022 3:30 PM ISTNew Delhi: Biocon Biologics, a subsidiary of biotechnology major Biocon, on Friday said the US health regulator has not approved an application for...
Biocon Biologics partner Viatris wins US court decision on 5 Sanofi Lantus SoloSTAR device patents Ruchika Sharma31 Dec 2021 5:12 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that the U.S. Court of Appeals for the Federal Circuit (USCAFC) has ...
Biocon arm gets DCGI nod to initiate clinical study for Itolizumab Ruchika Sharma24 Dec 2021 1:13 PM ISTItolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6-ALCAM pathway.
Biocon Biologics, Viatris to offer Insulin Glargine by Walgreens Prescription Savings Club Ruchika Sharma20 Nov 2021 2:14 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. have confirmed that Insulin Glargine (insulin glargine-yfgn)...
Biocon Biologics, Viatris launch interchangeable biosimilars Semglee, Insulin Glargine injections in US Ruchika Sharma17 Nov 2021 11:30 AM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., and Viatris Inc. today announced the U.S. launch of interchangeable biosimilars SEMGLEE...
Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids Ruchika Sharma15 Nov 2021 4:12 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 3:28 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Biocon Biologics gets 6 USFDA observations for Malaysia facility Ruchika Sharma27 Sept 2021 2:10 PM ISTBangalore: Pharma major Biocon has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with 6 observations...
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance Ruchika Sharma17 Sept 2021 12:48 PM ISTBengaluru: Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum...
Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar Semglee for diabetes Ruchika Sharma29 July 2021 1:33 PM ISTThe interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus, at the pharmacy counter, will be...
Biocon Biologics, Adagio Therapeutics join hands to advance antibody for COVID treatment Ruchika Sharma27 July 2021 1:27 PM ISTInitial data indicate that ADG20 could provide both rapid and durable protection against COVID-19 for up to one year.
